Brief: Inari Medical Q2 Revenue USD 145.82 Million Vs. IBES Estimate USD 143.7 Million
30/07/2024 21:05
Jul 30 (Reuters) - Inari Medical Q2 pretax profit USD -21.422 million vs. IBES estimate USD -11.5 million. * Q2 income from operations USD -22.444 million vs. IBES estimate USD -10.4 million * Q2 gross profit USD 125.827 million * Q2 net income USD -31.348 million vs. IBES estimate USD -10.4 million * outlook FY revenue USD 594.5-604.5 million
Recent news on Inari Medical
See all newsJ&J explores bid for Intra-Cellular Therapies, Bloomberg News reports (updated)
U.S. RESEARCH ROUNDUP-GE Healthcare, Summit Materials, Tapestry
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty